Targeting TOPK with OTS514 or OTS964 has been shown to effectively inhibit the growth of many human cancer cells [42], such as lung cancer and colorectal cancer [36, 43], and to suppress the metastasis of ovarian cancer [35, 44]. This evidence concerns the gene PBK and ovarian carcinoma.